Radify’s sci-fi plasma reactors could break China’s dominance of rare earth elements

Radify Metals has raised just under $3.0M and is developing a plasma-based reactor to reduce metal oxides into pure metals (targeting neodymium and dysprosium) with water vapor as the only waste. The company aims for several kilograms per day by year-end and a pilot capable of ~100 kg/day in the near term. Management projects near-term production costs ~50% above Chinese prices with potential to reach parity or lower at scale; the tech could materially diversify non-Chinese rare-earth supply and lower pollution vs conventional reduction methods.

Analysis

A low-cost, modular route to convert oxides into metals would be a structural wedge in the rare-earth/magnet supply chain: it changes where price formation and margin capture sit (from bulk mining and centralized separation toward onshore, agile processing). That re-shoring reduces the value of scale-driven incumbency but increases optionality for miners and OEMs that can pivot feedstock — think per-ton margin compression in China offset by higher domestic processing margins and reduced delivery risk.

Winners beyond obvious miners are power-electronics suppliers, hydrogen/electrolyser OEMs, and specialist powder-handling/filtration providers — the technology stack to run plasma-at-scale is materially different from smelting and will generate multi-year OEM and retrofit demand. Second-order beneficiaries include defense primes and EV motor suppliers because secured domestic processing short-circuits single-source geopolitical risk premiums baked into procurement and inventory policies.

Key risks are classical scale and cost curves: energy intensity, catalyst/consumable life, powder handling throughput, and permitting for industrial hydrogen use; any one can delay commercial parity by 18–36 months or permanently increase unit costs versus incumbent routes. The largest policy/counterparty risk is a rapid Chinese supply response (price dumping, subsidy acceleration, or upstream vertical integration) that can keep spot prices depressed for several years, forcing smaller Western players to either consolidate or exit.

The consensus underestimates capex and feedstock logistics: moving from lab kilos to hundreds of kg/day requires repeatable yields, glass-house permitting, and long-term offtakes to underwrite financing; investors should therefore pay a premium for proven pilot-scale throughput and signed offtake rather than pure IP claims.

Key Decisions for Investors

• Buy MP Materials (MP) 12–24 month call options (or 20–30% overweight cash equity) sized no more than 2% NAV: thesis is accelerating Western midstream capture. Target 2.5x upside if commercial-scale offtakes announced; cap premium (100%+ loss) if technologies fail to scale—use a 35–45% trailing stop or hedge with short-dated puts.
• Add Lynas (LYC.AX / LYSCF ADR) on dips, 6–18 month horizon, 1–2% NAV: acts as defensive onshore processor exposure. Reward: re-rating as customers de-risk China exposure; Risk: operational hiccups or longer-than-expected ramp—trim into any +25% move.
• Initiate a 6–12 month tactical long in a power-electronics leader (ON Semiconductor, ON) at 1% NAV: benefits from demand for efficient drivers for plasma and modular reactors. Expect 20–50% upside if industrial adoption accelerates; downside limited by diversified end-market exposure—use 20% stop-loss.
• Small thematic exposure to electrolyser/hydrogen supply (Nel ASA, NEL) via 12–36 month equity or call spread (0.5–1% NAV): hydrogen supply scaling is a key conditionality. Upside material if green H2 capex subsidies hit; downside is slower policy rollouts—cap position size accordingly.